Trial No.: Eli Lilly I5B-MC-JGDP
Phase 1b (Open-Label)/Phase 2 (Randomized, Double Blinded) Study Evaluating nab-Paclitaxel and Gemcitabine with or without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer.
Trial No.: ARMO AM0010-301 ARTIST 1
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer that Have Progressed During or Following a First-Line Gemcitabine Containing Regimen
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.